| Blocking interleukin (IL) 4-and IL13-mediated phosphorylation of STAT6 (Tyr641) decreases M2 polarization of macrophages and protects against macrophage-mediated … OM Rahal, AR Wolfe, PK Mandal, R Larson, S Tin, C Jimenez, D Zhang, ... International Journal of Radiation Oncology* Biology* Physics 100 (4), 1034-1043, 2018 | 112 | 2018 |
| Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models AR Wolfe, NJ Trenton, BG Debeb, R Larson, B Ruffell, K Chu, W Hittelman, ... Oncotarget 7 (50), 82482, 2016 | 90 | 2016 |
| miR-141-mediated regulation of brain metastasis from breast cancer BG Debeb, L Lacerda, S Anfossi, P Diagaradjane, K Chu, A Bambhroliya, ... Journal of the National Cancer Institute 108 (8), djw026, 2016 | 76 | 2016 |
| Predictors of response, progression-free survival, and overall survival in patients with lung cancer treated with immune checkpoint inhibitors RM Memmott, AR Wolfe, DP Carbone, TM Williams Journal of Thoracic Oncology 16 (7), 1086-1098, 2021 | 60 | 2021 |
| Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism BG Debeb, L Lacerda, R Larson, AR Wolfe, S Krishnamurthy, JM Reuben, ... Oncotarget 7 (19), 28329, 2016 | 60 | 2016 |
| Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a AR Wolfe, BG Debeb, L Lacerda, R Larson, A Bambhroliya, X Huang, ... Breast cancer research and treatment 154, 495-508, 2015 | 60 | 2015 |
| High-density and very-low-density lipoprotein have opposing roles in regulating tumor-initiating cells and sensitivity to radiation in inflammatory breast cancer AR Wolfe, RL Atkinson, JP Reddy, BG Debeb, R Larson, L Li, H Masuda, ... International Journal of Radiation Oncology* Biology* Physics 91 (5), 1072-1080, 2015 | 43 | 2015 |
| Inhibiting BRAF Oncogene–Mediated Radioresistance Effectively Radiosensitizes BRAFV600E-Mutant Thyroid Cancer Cells by Constraining DNA Double-Strand … R Robb, L Yang, C Shen, AR Wolfe, A Webb, X Zhang, M Vedaie, M Saji, ... Clinical Cancer Research 25 (15), 4749-4760, 2019 | 42 | 2019 |
| Combined Inhibition of IGF-1R/IR and Src family kinases enhances antitumor effects in prostate cancer by decreasing activated survival pathways F Dayyani, NU Parikh, AS Varkaris, JH Song, S Moorthy, T Chatterji, ... PloS one 7 (12), e51189, 2012 | 39 | 2012 |
| Neoadjuvant‐modified FOLFIRINOX vs nab‐paclitaxel plus gemcitabine for borderline resectable or locally advanced pancreatic cancer patients who achieved surgical resection AR Wolfe, D Prabhakar, VO Yildiz, JM Cloyd, M Dillhoff, L Abushahin, ... Cancer Medicine 9 (13), 4711-4723, 2020 | 32 | 2020 |
| Platinum‐based regimens versus cetuximab in definitive chemoradiation for human papillomavirus‐unrelated head and neck cancer TH Beckham, C Barney, E Healy, AR Wolfe, A Branstetter, A Yaney, ... International journal of cancer 147 (1), 107-115, 2020 | 21 | 2020 |
| MiR-33a decreases high-density lipoprotein-induced radiation sensitivity in breast cancer AR Wolfe, A Bambhroliya, JP Reddy, BG Debeb, L Huo, R Larson, L Li, ... International Journal of Radiation Oncology* Biology* Physics 95 (2), 791-799, 2016 | 20 | 2016 |
| Increasing neutrophil-to-lymphocyte ratio following radiation is a poor prognostic factor and directly correlates with splenic radiation dose in pancreatic cancer AR Wolfe, M Siedow, A Nalin, D DiCostanzo, ED Miller, DA Diaz, A Arnett, ... Radiotherapy and Oncology 158, 207-214, 2021 | 14 | 2021 |
| Breast cancer stem cell correlates as predicative factors for radiation therapy AR Wolfe, WA Woodward Seminars in radiation oncology 25 (4), 251-259, 2015 | 12 | 2015 |
| Altered gemcitabine and nab-paclitaxel scheduling improves therapeutic efficacy compared with standard concurrent treatment in preclinical models of pancreatic cancer AR Wolfe, R Robb, A Hegazi, L Abushahin, L Yang, DL Shyu, JG Trevino, ... Clinical Cancer Research 27 (2), 554-565, 2021 | 9 | 2021 |
| A microRNA-based signature predicts local-regional failure and overall survival after pancreatic cancer resection AR Wolfe, P Wald, A Webb, N Sebastian, S Walston, R Robb, W Chen, ... Oncotarget 11 (10), 913, 2020 | 9 | 2020 |
| Lack of breastfeeding history in parous women with inflammatory breast cancer predicts poor disease-free survival SR Stecklein, JP Reddy, AR Wolfe, MS Lopez, TM Fouad, BG Debeb, ... Journal of Cancer 8 (10), 1726, 2017 | 9 | 2017 |
| Clinical outcomes and multidisciplinary patterns of failure for olfactory neuroblastoma: the Ohio state experience AR Wolfe, D Blakaj, N London, A Blakaj, B Klamer, J Pan, P Wakely, ... Journal of Neurological Surgery Part B: Skull Base 81 (03), 287-294, 2020 | 7 | 2020 |
| BRAF mutation correlates with worse local–regional control following radiation therapy in patients with stage III melanoma AR Wolfe, P Chablani, MR Siedow, ED Miller, S Walston, KL Kendra, ... Radiation Oncology 16, 1-9, 2021 | 6 | 2021 |
| Morphologic changes associated with neoadjuvant-treated pancreatic ductal adenocarcinoma and comparison of two tumor regression grading systems J Vazzano, WL Frankel, AR Wolfe, TM Williams, W Chen Human Pathology 109, 1-11, 2021 | 5 | 2021 |
Wendy WoodwardProfessor, MD Anderson Cancer CenterVerified email at mdanderson.org
